Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
life sciences
2
×
bioinnovation capital
biolabs
boston
boston blog main
chemotherapy
daraprim
deals
drug pricing
drugs
epipen
epipens
exome
gene therapy
generic drugs
genetic testing
insulin
invitae
johannes fruehauf
labcentral
life science
martin shkreli
mylan
national blog main
national xcon
non-invasive prenatal tests
novartis
oncology
peter kolchinsky
prenatal tests
price collusion
san francisco
san francisco blog main
san francisco top stories
singular bio
spinal muscular atrophy
startups
svb leerink. puneet souda
the biotech social contract
What
medical
wide
2
×
ability
acquire
array
babies
bio
biotech
business
cost
deal
driving
drug
expand
genetic
good
healthcare
history
improved
industry
innovation
innovations
investment
invitae
life
long
low
maker
offers
outcomes
prenatal
pricing
proud
public
reached
sciences
screen
singular
test
tests
Language
unset
Current search:
wide
×
photo
×
" life sciences "
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
